Overview
Recurrent Thyroid Cancer is the reappearance of thyroid malignancy after initial treatment, occurring either as locoregional disease in the thyroid bed, remnant tissue, or cervical lymph nodes, or as distant metastasis. Recurrence reflects residual or treatment-resistant tumor cells and is influenced by the original histological type, tumor size, extrathyroidal extension, nodal burden, and completeness of surgery and radioactive iodine therapy. Detection relies on serum thyroglobulin monitoring, neck ultrasonography, radioiodine imaging, and cross-sectional studies, with rising tumor markers often signaling relapse before it is clinically apparent. Management is individualized and may involve revision surgery, additional radioiodine, image-guided ablation, external-beam radiation, or systemic targeted therapy for iodine-refractory disease. The peer-reviewed research in this area addresses the diagnosis, monitoring, and treatment of thyroid carcinoma relevant to recurrence and long-term outcomes, including image-guided ablation of thyroid tumors, molecular diagnosis informing clinical management, long-term retrospective evaluation of treatment outcomes in well-differentiated disease, secular trends in thyroidectomy incidence, the role of transcription-factor activity in Thyroid Cancer cell proliferation, the adequacy of preoperative evaluation in medullary Thyroid Cancer, and radiation-exposure considerations after radioiodine ablation. Recurring themes include surveillance strategy, the molecular and pathological predictors of relapse, the use of minimally invasive and ablative techniques, and the optimization of follow-up to balance early detection against overtreatment.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Molecular Diagnosis in Clinical Management and Diagnosis of Thyroid Cancer
Primary Leiomyosarcoma of the Thyroid; a Case Report and a Review of Recent Literature
In The Pursuit of The Perfect Thyroid Care
Secular Trend in the Incidence of Japanese Employees with Thyroid Cancer Undergoing Thyroidectomy from 2005 to 2014: a Retrospective Descriptive Study Using an Employment-Based Insurance Claims Database
Thyroid Transcription Factor-1 Activity is Required for the Proliferation of Human Thyroid Cancer Cells 8505C
Outcomes of Differentiated Thyroid Cancer Patients Treated with Surgery and Radioactive Iodine at SQCCCRC
Medullary Thyroid Cancer: Is the Adequacy of Pre-Operative Evaluation Influenced by Training Background?
Evaluation of Household Radiation Exposure and Safety after Ambulatory Radioiodine Ablation Therapy
Leiomyosarcoma of the Thyroid Gland: A Review of the Literature and our Experience
Metastatic Malignant Peripheral Nerve Sheath Tumor to the Thyroid
How this research is being cited
The 12 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Wan Nabila Wan Mansor et al. · 2023 · The Egyptian Journal of Otolaryngology
-
2023 · The Egyptian Journal of Otolaryngology
-
2023 · Journal of Thyroid Cancer
-
2022 · Cancers
-
M. Kaur et al. · 2022 · Indian Journal of Pathology and Microbiology
-
2022 · Cancers
-
2022 · Indian Journal of Pathology and Microbiology
-
2022 · Medical & Clinical Research
A sample of recent works citing this journal's research on Recurrent Thyroid Cancer, linking to each citing work.